Document Detail


Notable relationship between the level of tumor marker TPS in serum and survival in breast cancer.
MedLine Citation:
PMID:  8687149     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tissue Polypeptide Specific antigen (TPS) in serum was measured once during the follow-up of 200 breast cancer patients and compared with survival. Within 12 months, patients with normal TPS (< 80 U/L) exhibited a 3% death rate (3/96), which was undistinguishable from the mortality of normal females of corresponding age. Patients with moderate TPS (80-400 U/L) suffered 19% death (14/72), and patients with high TPS (> 400 U/L) 72% death (23/32). The relative risk (RR) of death within 6 months was 1 with normal TPS, 8 with moderate TPS, and 48 with high TPS. RR for 12 months was 1, 6, and 23, respectively. Serum TPS at admission had a significant predictive value with regard to survival up to 12 months.
Authors:
K Bremer; G Eklund; B Björklund
Related Documents :
9776149 - Early experience of endoscopic extirpation of benign breast tumors via an extra-mammary...
23724529 - Ankaferd blood stopper in episiotomy repair.
23204799 - Astigmatic changes after horizontal rectus muscle surgery in intermittent exotropia.
24469919 - Physiological and morphological responses to the first bout of refeeding in southern ca...
24739149 - Effects of minimally invasive procedures for evacuation of intracerebral hematoma in ea...
12271279 - Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of...
8838729 - Arthroscopic assisted rotator cuff repair: results using a mini-open deltoid splitting ...
9458249 - Thigh pain following tourniquet application in simultaneous bilateral total knee replac...
20151839 - Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the tre...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  16     ISSN:  0250-7005     ISO Abbreviation:  Anticancer Res.     Publication Date:    1996 Mar-Apr
Date Detail:
Created Date:  1996-08-21     Completed Date:  1996-08-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  905-9     Citation Subset:  IM    
Affiliation:
Clinic of Hematology and Oncology, Bochum, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Breast Neoplasms / blood*,  mortality*
Female
Humans
Peptides / blood*
Prognosis
Time Factors
Tumor Markers, Biological / blood*
Chemical
Reg. No./Substance:
0/Peptides; 0/Tumor Markers, Biological; 0/tissue polypeptide specific antigen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuc...
Next Document:  Adjuvant treatment for breast cancer in the elderly.